Blue Water Vaccines Inc. License Agreements
9 Contracts & Agreements
- License Agreement, dated March 27, 2023, between Proteomedix and Laboratory Corporation of America Holdings (Filed With SEC on April 11, 2024)
- Patent & Technology License Agreement, dated November 18, 2022, between the Company and the University of Texas Health Science Center at San Antonio (Filed With SEC on May 12, 2023)
- Amendment #1 to Exclusive License Agreement, dated as of May 11, 2022, by and between the Registrant and St. Jude Childrens Research Hospital, Inc (Filed With SEC on May 13, 2022)
- Exclusive License Agreement between the Registrant and St. Jude Childrens Research Hospital, Inc., effective as of January 27, 2020 (Filed With SEC on November 29, 2021)
- License Agreement between the Registrant and Oxford University Innovation Limited, effective as of July16, 2019 (Filed With SEC on November 29, 2021)
- Exclusive License Agreement between the Registrant and Childrens Hospital Medical Center, d/b/a Cincinnati Childrens Hospital Medical Center, effective as of June 1, 2021 (Filed With SEC on November 29, 2021)
- Exclusive License Agreement between the Registrant and St. Jude Childrens Research Hospital, Inc., effective as of January 27, 2020 (Filed With SEC on November 5, 2021)
- License Agreement between the Registrant and Oxford University Innovation Limited, effective as of July16, 2019 (Filed With SEC on November 5, 2021)
- Exclusive License Agreement between the Registrant and Childrens Hospital Medical Center, d/b/a Cincinnati Childrens Hospital Medical Center, effective as of June 1, 2021 (Filed With SEC on November 5, 2021)
